These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28830871)

  • 1. Cell-Free Circulating DNA Integrity Based on Peripheral Blood as a Biomarker for Diagnosis of Cancer: A Systematic Review.
    Cheng J; Tang Q; Cao X; Burwinkel B
    Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1595-1602. PubMed ID: 28830871
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma cell-free DNA integrity plus circulating tumor cells: a potential biomarker of no distant metastasis breast cancer.
    Wang W; Liang M; Ma G; Li L; Zhou W; Xia T; Xie H; Wang S
    Neoplasma; 2017; 64(4):611-618. PubMed ID: 28485169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer.
    Cheng J; Holland-Letz T; Wallwiener M; Surowy H; Cuk K; Schott S; Trumpp A; Pantel K; Sohn C; Schneeweiss A; Burwinkel B
    Breast Cancer Res Treat; 2018 May; 169(1):69-82. PubMed ID: 29340881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case-Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection.
    Bortul M; Giudici F; Tierno D; Generali D; Scomersi S; Grassi G; Bottin C; Cappelletti MR; Zanconati F; Scaggiante B
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating cell-free DNA variables as marker of ovarian cancer patients: A pilot study.
    Stamenkovic S; Cheng J; Surowy H; Burwinkel B; Gündert M
    Cancer Biomark; 2020; 28(2):159-167. PubMed ID: 32176629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alter circulating cell-free DNA variables in plasma of ovarian cancer patients.
    Yu Z; Qin S; Wang H
    J Obstet Gynaecol Res; 2019 Nov; 45(11):2237-2242. PubMed ID: 31502389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence.
    Cheng J; Cuk K; Heil J; Golatta M; Schott S; Sohn C; Schneeweiss A; Burwinkel B; Surowy H
    Oncotarget; 2017 Aug; 8(33):54537-54547. PubMed ID: 28903362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis.
    Madhavan D; Wallwiener M; Bents K; Zucknick M; Nees J; Schott S; Cuk K; Riethdorf S; Trumpp A; Pantel K; Sohn C; Schneeweiss A; Surowy H; Burwinkel B
    Breast Cancer Res Treat; 2014 Jul; 146(1):163-74. PubMed ID: 24838941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor DNA
    Sun X; Li H; Sun M; Yuan Y; Sun L
    Future Oncol; 2019 Oct; 15(30):3513-3525. PubMed ID: 31578881
    [No Abstract]   [Full Text] [Related]  

  • 10. Liquid biopsies in thyroid cancers: a systematic review and meta-analysis.
    Zeyghami W; Hansen MU; Jakobsen KK; Groenhøj C; Feldt-Rasmussen U; von Buchwald C; Hahn CH
    Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37882489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid Biopsy Technique May Allow Early Screening.
    Cancer Discov; 2017 Nov; 7(11):1207. PubMed ID: 28903989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of circulating biomarkers in liquid biopsy diagnostics.
    Yeo JC; Lim CT
    Biotechniques; 2018 Oct; 65(4):187-189. PubMed ID: 30284936
    [No Abstract]   [Full Text] [Related]  

  • 13. Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III).
    Thakur S; Tobey A; Daley B; Auh S; Walter M; Patel D; Nilubol N; Kebebew E; Patel A; Jensen K; Vasko V; Klubo-Gwiezdzinska J
    Front Oncol; 2019; 9():905. PubMed ID: 31620364
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in Cancer Therapy: Liquid Biopsy.
    Marmé D
    Oncol Res Treat; 2017; 40(7-8):402-403. PubMed ID: 28728143
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grail to pour $1 billion into blood test to detect early cancer.
    Sheridan C
    Nat Biotechnol; 2017 Feb; 35(2):101-102. PubMed ID: 28178244
    [No Abstract]   [Full Text] [Related]  

  • 17. Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis.
    Lin Z; Neiswender J; Fang B; Ma X; Zhang J; Hu X
    Oncotarget; 2017 Apr; 8(16):26625-26636. PubMed ID: 28460452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.
    Cirmena G; Ferrando L; Ravera F; Garuti A; Dameri M; Gallo M; Barbero V; Ferrando F; Del Mastro L; Garlaschi A; Friedman D; Fregatti P; Ballestrero A; Zoppoli G
    JCO Precis Oncol; 2022 Feb; 6():e2100198. PubMed ID: 35201850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
    Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
    Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis.
    Rokkas T; Kothonas F; Rokka A; Koukoulis G; Symvoulakis E
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):819-25. PubMed ID: 25856691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.